← Back to catalogue
Research draft

DL-methionine

vr.tr.dl-methionine · PHY.MAT

Enable an AI agent to recognise DL-methionine, assess the identity and condition of a particular lot, and determine its suitability for a specified handling, processing or use context.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

Researched by: Codex + Grok

Purpose and description

Enable an AI agent to recognise DL-methionine, assess the identity and condition of a particular lot, and determine its suitability for a specified handling, processing or use context.

The racemic mixture of the D and L enantiomers of methionine, C5H11NO2S, a sulfur-containing amino acid produced synthetically and used mainly as a feed additive and nutritional supplement; CAS 59-51-8.

It can be Authenticate a lot using complementary chemical-identity, assay and stereochemical evidence.; Calculate the material mass required for a specified methionine amount using the measured assay and its reporting basis.; Assess whether a lot can be dissolved, transferred or mixed under specified process conditions.; Compare lots for a proposed substitution while preserving differences in stereochemistry, grade, impurities and physical behaviour.; Accept, quarantine, reject or request retesting of material against a declared specification.; Select handling and storage controls from the supplied product evidence and observed material condition..

Distinguishing features

Match the molecular identity to methionine, C5H11NO2S, with the racemic substance identifier CAS 59-51-8; the name or identifier alone does not authenticate a sample. Reference: [PubChem DL-methionine](https://pubchem.ncbi.nlm.nih.gov/compound/DL-Methionine).

Use an enantiomer-resolving measurement to establish approximately equal D and L fractions within an explicitly selected tolerance, distinguishing DL-methionine from either isolated enantiomer or an unspecified mixture.

Confirm the amino-acid structure rather than a methionine hydroxy analogue; a shared nutritional purpose is insufficient evidence of chemical identity.

Establish whether the supplied material is the free amino acid, a salt or a coated or diluted formulation before treating its gross mass as DL-methionine mass.

Distinguish free methionine from peptide-bound methionine and oxidation products using methods whose sample preparation and selectivity support that distinction.

Scope

+ Chemical identity and evidence for the D:L enantiomer composition

+ Lot-specific methionine content, moisture, impurities and analytical confidence

+ Physical presentation, dissolution behaviour and suitability for material transfer or mixing

+ Storage history, packaging integrity and evidence of deterioration

+ Material suitability for a declared grade, process and intended use

- D-methionine and L-methionine as separately specified substances

- Methionine salts, hydroxy analogues, esters and methionine-containing peptides

- Complete feeds, supplements, premixes and protected-delivery formulations containing DL-methionine

- Organism-level methionine metabolism, nutritional requirements and therapeutic outcomes

- Manufacturing plants, synthesis processes and jurisdictional authorisation systems

Characteristics

Chemical identity confidence
unverified | supported | conflicting Prevents a supplier label or nonspecific assay from being treated as proof of DL-methionine identity.
D:L enantiomer composition
mol% D and mol% L among measured methionine, with method and uncertainty Establishes racemic composition independently of total methionine content.
Methionine assay
% by mass, explicitly as received or on a stated dry basis Supports active-mass calculations and comparison with a selected material specification.
Water content
% by mass, with water-specific or loss-on-drying method identified Affects assay interpretation and may help explain changes in handling condition.
Related substances and contaminants
Named analytes in mg/kg or % by mass, with reporting limits Distinguishes methionine content from overall lot suitability and identifies relevant impurity or deterioration concerns.
Physical presentation
crystalline powder | granules | dissolved material | other declared presentation Determines which sampling, dissolution and transfer observations are needed.
Particle-size distribution
µm distribution or sieve fractions, with measurement method Supports judgments about dust generation, mixing and segregation in a specified process.
Dissolution performance
Achieved g/L and dissolution time at recorded solvent, temperature, pH and agitation Tests whether a proposed solution preparation is feasible under actual operating conditions.
Grade and specification
Named specification, revision, supplier claim and intended application Prevents chemical identity from being mistaken for suitability for every use.
Lot disposition
unassessed | quarantined | accepted for stated use | rejected | retest required Makes the material decision conditional on evidence, purpose and assessment date.

Also called

(1-¹³C)MethionineL-methionineD-methionineL-methionine zwitterionD-methionine zwitterionL-methioninateL-methioniniumD-methioninateD-methioniniummethioninatemethioniniummethionine c-11L-(1-¹³C)Methionine(2-³H)Methionine(Methyl-11C)-D-methionone

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 11 findings · 21 questions.

Methionine identity and racemate Establish what substance is present and whether its stereochemical composition supports the DL-methionine designation.

Methionine names, total-content assays and nutritional roles do not by themselves distinguish the racemate from neighbouring substances.

Molecular identity

Connect the declared substance to evidence from the actual material.

Free methionine identity

Record evidence separating free methionine from salts, hydroxy analogues, peptides and formulated products.

  1. Which measurements support methionine identity in this sample, and which plausible substitutes or related compounds do they distinguish? measurement
  2. Does the lot represent free DL-methionine or a preparation whose carrier, counterion, coating or other constituents require a linked model? boundary

Enantiomer composition

Assess racemic composition separately from chemical purity.

Racemate evidence

Require a defensible D:L result and acceptance tolerance; apparent optical inactivity alone is insufficient to establish composition.

  1. What D and L fractions were measured, using which resolving method and with what uncertainty? measurement
  2. What specification defines the acceptable departure from equal D and L fractions for this material? definition
Assay and chemical quality Determine how much methionine the material contains and which additional constituents affect its suitability.

A total-methionine result cannot establish stereochemistry, impurity acceptability or equivalence between wet and dry reporting bases.

Methionine quantity

Interpret the reported assay through its method, sample preparation and calculation basis.

Interpretable methionine assay

Record what the assay measures and whether it supports the intended material calculation. Analytical context: [European Commission reference laboratory report](https://joint-research-centre.ec.europa.eu/system/files/2013-02/FinRep-FAD-2010-0023.pdf).

  1. What methionine content was measured, on what moisture basis, and does sample preparation measure free methionine or a broader total? measurement
  2. What mass of this lot supplies the requested methionine amount after accounting for assay basis and any dilution? action

Non-methionine constituents

Assess water, related substances and route-dependent contaminants without assuming an unreported impurity profile.

Impurity coverage

Separate measured absence, values below reporting limits and constituents that were never tested.

  1. Which related substances, oxidation products, residual reagents or other contaminants are relevant to the documented production route and intended use? provenance
  2. Which of those constituents were tested, at what reporting limits, and how do the results compare with the selected specification? measurement
Physical form and processing Describe how the supplied DL-methionine behaves during transfer, mixing and solution preparation.

Chemically comparable lots may behave differently during weighing, blending and dissolution, affecting actual delivery of methionine.

Particulate behaviour

Assess particle properties and their consequences for a specified dry-material process.

Transfer and mixing fitness

Connect particle size, bulk behaviour and observed dust or agglomeration to equipment and mixture requirements.

  1. What particle-size distribution, bulk density, flow behaviour and dustiness characterise this lot under relevant test conditions? measurement
  2. Can the intended equipment meter and distribute this lot consistently, or is a validated preparation or mixing adjustment needed? action

Solution preparation

Evaluate dissolution in the actual solvent and operating window.

Achievable dissolved concentration

Record empirical dissolution limits and distinguish slow dissolution from insoluble contamination or subsequent precipitation.

  1. At the intended solvent composition, pH, temperature and mixing time, what concentration dissolves and what residue remains? measurement
  2. Will cooling, dilution or a pH change leave the preparation suitable for its intended use, and what verification is needed? action
Preservation and handling Assess whether storage and exposure history have changed the material or the controls needed to handle it.

The current state of a DL-methionine lot depends on its history, including moisture exposure, possible chemical change and dust-generating operations.

Condition over time

Link observations and retest results to packaging, storage excursions and possible deterioration.

Continued material conformity

Assess changes in methionine assay, relevant oxidation products, moisture and physical condition against earlier evidence.

  1. What packaging breaches or storage excursions occurred, and which material attributes could they have affected? provenance
  2. Do current assay, impurity and physical-condition results support continued use or require retesting or quarantine? action

Operation-specific exposure

Translate product-specific safety information into controls for the intended material operation.

Supported handling controls

Base handling decisions on the actual product form, current safety documentation and process exposure evidence.

  1. Which supplier safety document applies to this lot, grade and presentation, and what handling or incompatibility information does it establish? provenance
  2. What containment, exposure control and cleanup measures are justified for the planned weighing, transfer or mixing operation? action
Use suitability and substitution Determine whether the evidenced material meets the requirements of a particular application.

DL-methionine identity does not establish grade compliance, biological equivalence or permission for a particular use.

Application requirements

Connect lot evidence to the specified use, grade and applicable external requirements.

Qualified use decision

Record a suitability decision limited to the application and requirements actually assessed.

  1. What application, grade specification and externally verified use conditions must this lot satisfy? boundary
  2. Which requirements are supported by lot-specific evidence, and which missing results prevent acceptance? action

Substitution boundaries

Separate equal methionine mass from equivalent processing or biological performance.

Evidence-bounded equivalence

Compare alternative lots or methionine sources using explicit criteria rather than a shared ingredient name.

  1. Does the proposed replacement differ in enantiomer composition, assay basis, chemical form, coating, impurity profile or delivery behaviour? boundary
  2. What evidence from the linked formulation, process or organism model supports substitution, and what recalculation or validation is required? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Kinds and varieties

Reported by the breadth pass; each item needs checking against its source before it becomes normative.

  • research
  1. Which of these kinds and varieties hold for the sense of DL-methionine this model covers, and on what evidence? provenance

What the second pass must settle

  • Does an existing Vercy world model already own DL-methionine or an encompassing substance concept to which this registry entry should link?
  • Which authoritative specifications should define racemic tolerance, assay basis and impurity limits for each intended grade?
  • Which analytical methods adequately distinguish D and L methionine, free and bound methionine, and relevant oxidation products in the material matrices encountered?
  • What product-specific stability evidence supports storage limits, retest intervals and decisions after moisture or temperature excursions?
  • For each proposed application, what current use conditions and evidence of equivalence govern substitution for other methionine sources?